Microbial Caffeic Acid Synthesis via Soluble Enzyme Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing caffeic acid are inefficient and costly due to the challenges of expressing membrane-bound enzymes like cinnamate 4-hydroxylase (C4H) and p-coumarate 3-hydroxylase (C3H) in microbial systems, which are essential for the plant-based phenylpropanoid pathway, and rely on feeding direct precursors like tyrosine and p-coumaric acid, increasing production costs.
Innovation Solution
Metabolically engineering microbial cells, such as E. coli, to overexpress tyrosine ammonia lyase (TAL) and 4-hydroxyphenylacetate 3-hydroxylase (4HPA3H), which bypasses the need for C4H and C3H by using tyrosine as a precursor, allowing for the production of caffeic acid through a dual metabolic pathway involving tyrosine and L-dopa intermediates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If plant-specific cytochrome P450 dependent monooxygenases (C4H and C3H) are used for caffeic acid production, then the phenylpropanoid pathway can be established, but the enzymes' instability and membrane-bound property make purification and characterization challenging and reduce production efficiency
Solution Approach 1:
The invention extracts and replaces the problematic membrane-bound cytochrome P450 dependent monooxygenases (C4H and C3H) with a soluble microbial enzyme system. Specifically, it uses a microbial C3H enzyme from Saccharothrix espanaensis that is not membrane-bound and can function in soluble form, thereby eliminating the purification and stability issues associated with plant-specific membrane enzymes while maintaining the phenylpropanoid pathway functionality.
Solution Approach 2:
The invention creates a functional copy of the plant phenylpropanoid pathway using microbial enzymes. Instead of directly using plant C4H and C3H enzymes, it employs a microbial C3H enzyme that replicates the hydroxylation function at the 3-position of p-coumaric acid, and introduces a bacterial C4H enzyme that performs the 4-hydroxylation, thereby copying the essential pathway functions with more stable and manufacturable enzymes.
2Productivity
If direct precursors (tyrosine and p-coumaric acid) are fed to produce caffeic acid, then production can be achieved, but production costs increase
Solution Approach 1:
The invention performs preliminary action by introducing the complete biosynthetic pathway enzymes (microbial C3H and bacterial C4H) into the microbial host, enabling the organism to synthesize caffeic acid de novo from simple carbon sources. This eliminates the need to feed expensive direct precursors like tyrosine and p-coumaric acid, as the engineered microorganism can produce these intermediates itself through the introduced enzymatic pathway.
Solution Approach 2:
The engineered microorganism becomes self-sufficient for caffeic acid production by incorporating the necessary enzymatic pathway. The microbe uses its own metabolic machinery to convert simple carbon sources into caffeic acid through the introduced C4H and C3H enzymes, eliminating dependence on external provision of expensive precursor compounds.
3Adaptability or versatility
If microbial systems are used for caffeic acid production, then extraction from plant sources can be replaced, but expressing membrane-bound enzymes in microbial systems remains challenging
Solution Approach 1:
The invention replaces complex, unstable plant membrane-bound enzymes with simpler, soluble microbial enzymes that are easier to express and maintain. The microbial C3H enzyme from Saccharothrix espanaensis and the bacterial C4H enzyme are chosen for their stability and ease of expression in microbial hosts, effectively substituting the problematic plant enzymes with more practical alternatives suitable for industrial production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the de novo synthesis of caffeic acid from simple carbon sources, reducing production costs and overcoming the limitations of expressing membrane-bound enzymes, achieving higher titers of caffeic acid production, such as 50.2 mg/L in shake flasks.
Implementation Method 1
A tyrosine ammonia lyase (TAL) encoded by sam8 and a microbial C3H encoded by sam5 are responsible for the conversion of tyrosine to p-coumaric acid
Implementation Method 2
the conversion of tyrosine to p-coumaric acid and then to caffeic acid, respectively
Implementation Method 3
a two-step sequential hydroxylation at the 4- and 3-position of the benzyl ring, cinnamic acid is converted into caffeic acid
Implementation Method 4
allowing for the production of caffeic acid through a dual metabolic pathway involving tyrosine and L-dopa intermediates
Data Source
AI summary
Microorganisms are genetically engineered to synthesize caffeic acid from simple carbon sources via a tyrosine intermediate by means of a dual pathway that utilizes both endogenous and engineered enzymatic activities.